|  Results
of the APEX Trial: Bortezomib (Velcade®) Delays Progression of
Advanced Multiple Myeloma Longer than Standard Therapy
Write-up
from NCI's Developmental Therapeutics Program
The
role of bortezomib in the treatment of lymphoma
The
proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma
cell lines in vitro.
Bortezomib
in combination with celecoxib in patients with advanced solid
tumors
Bortezomib
in relapsed or refractory mantle cell lymphoma (MCL): Results
of the PINNACLE study.
Bortezomib
ups survival of mice with lupus - it eliminated autoantibody
production (a problem in autoimmune disorders), attenuated nephritis
and improved survival.
|
Bortezomib
What Is Bortezomib?